We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
+20.49%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$149M
Cap. Flow
+$143M
Cap. Flow %
71%
Top 10 Hldgs %
12.72%
Holding
641
New
154
Increased
108
Reduced
3
Closed
376

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.86M
2
LHX icon
L3Harris
LHX
+$2.73M
3
SRE icon
Sempra
SRE
+$2.69M
4
CME icon
CME Group
CME
+$2.65M
5
GPN icon
Global Payments
GPN
+$2.53M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$760K
2
AEP icon
American Electric Power
AEP
+$752K
3
PG icon
Procter & Gamble
PG
+$749K
4
V icon
Visa
V
+$715K
5
EA icon
Electronic Arts
EA
+$650K

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Financials 15.1%
3 Healthcare 13.84%
4 Consumer Discretionary 10.58%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRL icon
426
Hormel Foods
HRL
$13.9B
– –
-2,026
Closed -$94K
HUBB icon
427
Hubbell
HUBB
$25.2B
– –
-128
Closed -$15K
HUBS icon
428
HubSpot
HUBS
$12.3B
– –
-129
Closed -$17K
HUM icon
429
Humana
HUM
$45B
– –
-595
Closed -$187K
IART icon
430
Integra LifeSciences
IART
$1.39B
– –
-2,237
Closed -$100K
IDA icon
431
Idacorp
IDA
$8.32B
– –
-3,425
Closed -$301K
INCY icon
432
Incyte
INCY
$24B
– –
-644
Closed -$47K
INDB icon
433
Independent Bank
INDB
$4.05B
– –
-699
Closed -$45K
IONS icon
434
Ionis Pharmaceuticals
IONS
$9.06B
– –
-343
Closed -$16K
IP icon
435
International Paper
IP
$21.9B
– –
-1,545
Closed -$46K
IQV icon
436
IQVIA
IQV
$38.4B
– –
-66
Closed -$7K
IR icon
437
Ingersoll Rand
IR
$34.1B
– –
-285
Closed -$7K
IRM icon
438
Iron Mountain
IRM
$36.9B
– –
-7,395
Closed -$176K
ITT icon
439
ITT
ITT
$17.7B
– –
-23
Closed -$1K
JBGS
440
JBG SMITH
JBGS
$829M
– –
-3,297
Closed -$105K
JBLU icon
441
JetBlue
JBLU
$2.35B
– –
-17,875
Closed -$160K
JEF icon
442
Jefferies Financial Group
JEF
$12.8B
– –
-7,318
Closed -$96K
JLL icon
443
Jones Lang LaSalle
JLL
$16.8B
– –
-51
Closed -$5K
KDP icon
444
Keurig Dr Pepper
KDP
$42.1B
– –
-49
Closed -$1K
KEY icon
445
KeyCorp
KEY
$24.5B
– –
-10,018
Closed -$104K
KEYS icon
446
Keysight
KEYS
$55B
– –
-17
Closed -$1K
KKR icon
447
KKR & Co
KKR
$95.7B
– –
-3,827
Closed -$90K
KMI icon
448
Kinder Morgan
KMI
$69.9B
– –
-17,631
Closed -$245K
KMPR icon
449
Kemper
KMPR
$1.72B
– –
-9
Closed -$1K
KR icon
450
Kroger
KR
$35.7B
– –
-5,119
Closed -$154K
16 17
18
19 20

Similar funds

SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return

Pearl River Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Pearl River Capital held 641 positions worth $201M, up 288% from $51.8M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Pearl River Capital deployed $143M of net new capital in Q2 2020, opening 154 new positions and adding to 108 existing holdings. Its largest new stake was Biogen: 9,509 shares worth $2.54M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Applied Materials, an estimated $458K trimmed.

  • Pearl River Capital's largest Q2 2020 buy was Biogen: 9,509 shares worth $2.54M.
  • Pearl River Capital added most to L3Harris in Q2 2020, an estimated $2.73M increase.
  • Pearl River Capital's biggest Q2 2020 reduction was Applied Materials, cutting an estimated $458K.
  • Pearl River Capital fully exited Gilead Sciences in Q2 2020, selling an estimated $760K.
  • Pearl River Capital's ten largest holdings make up 13% of its $201M portfolio in Q2 2020.
  • Pearl River Capital opened 154 new positions and closed 376 in Q2 2020.
  • Pearl River Capital's portfolio value rose 288% quarter-over-quarter to $201M.

Based on Pearl River Capital's 13F filing for Q2 2020, filed 10 Aug 2020.